Sentences with phrase «cell products manufacturing»

Not exact matches

Tesla has announced that it will be collaborating with Japanese electronics giant, Panasonic Corp., on manufacturing solar cell and modules for its energy storage products.
The partnership will see Tesla Motors integrate the solar cells and modules that Panasonic will begin manufacturing at the Buffalo facility next year into a solar energy system that will work with its energy storage products, the Powerwall and Powerpack.
Steven Kattman, Ph.D, is a leading expert in the development and manufacture of cell based products derived from Pluripotent Stem Cells.
In Mexico, Minebea Intec will offer an extensive range of weighing and inspection products, solutions and services for diverse manufacturing processes — from goods in to goods out, including platform scales, vessel and silo scales (load cells), checkweighers and equipment for detecting foreign objects (metal detectors and x-ray inspection systems), as well as software solutions for statistical process control and formulation applications.
The comprehensive product range includes industrial scales, terminals, load cells, weighing platforms and software from receiving raw materials through various manufacturing processes, in - line process control and end - of - line packaging control.
Due to the volume of product required, Aegg designed the bespoke automation and packaging solution for its client at the chosen manufacturing site, which included a dedicated manufacturing cell within an already established BRC Grade A facility.
He also told me that mercury cell chlor - alkali products were approved for use in food manufacturing and provided me with the Codex Standards that said how much mercury was allowed in the chlor - alkali products used to manufacture foods.
The Australian Stem Cell Centre is investing significant resources in pursuing this interest with a view to producing a manufactured, safe, and reliable supply of blood products from stem cells
When carbon dioxide is fed into the cell, electricity splits it into oxygen and solid carbon or carbon monoxide gas that could then be used to manufacture many different products and fuels.
And the world's largest producer of photovoltaic cells — Suntech — imports raw materials from U.S. suppliers and manufactures its high - technology product in China.
To make «clinical - grade» cells, scientists produced them without the use of any of the animal cells or products typically needed, and did so under certified manufacturing conditions.
Others include: toxic by - products from polysilicon manufacture dumped indiscriminately in China; air pollution spewed from coal - fired power plants that provide the electricity needed to produce photovoltaics; and recovering cadmium, a known human carcinogen that is a primary ingredient in some thin - film solar cells, from mining slimes.
In addition to an innovative method for cell purification, scientists also have at their disposal a new TUM facility for the sterile manufacture of cell products.
The basic chemistry of these and thousands of other manufactured compounds incorporated in everyday products do not appear in nature; they have entered our environment so recently that our genes, cells, brains, and bodies have not yet evolved mechanisms for coping with them.
While this study in Cell demonstrates proof - of - concept, the team is eager to secure the necessary partners and resources to proceed to the product development phase, followed up by scaled up manufacturing and distribution so that the diagnostic tool can be deployed for use in the field.
Supported by: Hear from leading expert Dr David DiGiusto, Stanford University School of Medicine, USA, as he shares his extensive experience in developing and optimizing manufacturing processes for cell and gene therapy products including:
Under his direction, plasmid DNA, CAR - T - cells, regulatory T - cells, engineered stem cell grafts and gene modified hematopoietic stem cell products have been manufactured and released for use in Phase I / II clinical trials.
This track will focus on aspects of cell processing relevant to manufacturing of cell - based products.
The cell processing track aims at reproducible, safe and sustainable methods applicable in manufacturing settings for cell - based products intended for cellular therapy.
His laboratory (The Laboratory for Cell and Gene Medicine) specializes in the development of manufacturing processes and QC assays and provides cGMP compliant clinical materials production and regulatory support activities for investigational cell produCell and Gene Medicine) specializes in the development of manufacturing processes and QC assays and provides cGMP compliant clinical materials production and regulatory support activities for investigational cell producell products.
This is in addition to the licensing of products such as GlaxoSmithKline's Strimvelis ex-vivo stem - cell therapy for treatment of severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA - SCID) in 2016 (1)-- has led to an increase in demand for therapeutic vector manufacturing capabilities.
Spin out of Harvard U, which utilizes technology for manufacturing beta - cell therapeutic product for diabetes, developed in Doug Melton's lab.
To deliver a functional cure for all patients with type 1 diabetes and an important new therapy for patients with type 2 disease that require insulin to maintain control, ViaCyte is developing products with numerous advantages including a virtually unlimited supply of cells manufactured under quality - controlled conditions, and a potentially safer and more optimal route of administration.
The use of human embryonic stem cells, as opposed to patient blood, as the starting material for AST - VAC2 provides a scalable system for the production of a large number of vaccine doses in a single lot, reducing manufacturing costs, enabling «off - the - shelf» availability, and ensuring product consistency.
Clinical Cell Processing News is a series about new protocols, products and techniques for clinical - grade cell processing and manufacturCell Processing News is a series about new protocols, products and techniques for clinical - grade cell processing and manufacturcell processing and manufacturing.
Invivoscribe offers a full range of hematology - oncology testing products and services (B - and T - cell clonality, NGS gene panels, MRD assays, and comprehensive bioinformatics software), all developed under ISO 13485 design control and manufactured in our own cGMP facility.
Embryonic stem cells, Adult stem cells, Reprogramming to pluripotency and lineage conversion, Directed differentiation, Germ cells, Genetic and epigenetic mechanisms, Stem cells in development, Stem cell niche, Cancer stem cells, Disease modeling and drug screening, Stem cell therapy, Clinical studies in regenerative medicine, Tissue engineering and biomaterials, Imaging and diagnostics, Stem cell products, manufacturing, and quality control, Ethical, legal, and social issues Read Journal
Because of intrinsic fragility, cell therapy products can be highly sensitive to variations in manufacturing procedures.
«We are tremendously grateful to the NIDDK for their support of our research characterizing pluripotent stem cell - derived human beta cells in vitro as well as our investigations into manufacturing methods for developing these cells into therapeutic products,» said Kevin D'Amour, Vice President, Research and Chief Scientific Officer at ViaCyte.
I want to help take stem cell - based tissues to the next level — to generate technologies that are actually being used by industry and are being implemented for the manufacturing of stem cell - based products.
In conclusion, we have developed a screening strategy that allows us to rapidly identify clinically approved drugs for use in a Chemistry, Manufacture and Control protocol that can be safely used to deplete unwanted contaminating precursor cells from a differentiated cell product.
In addition, ALB has exposure to renewable energy through the manufacture and marketing of products used in the production of solar cells.
VXGN has also listed its «a state - of - the - art biopharmaceutical manufacturing facility with a 1,000 - liter bioreactor that can be used to make cell culture or microbial biologic products
VXGN has other potentially valuable assets, including a «a state - of - the - art biopharmaceutical manufacturing facility with a 1,000 - liter bioreactor that can be used to make cell culture or microbial biologic products» and rights to specified percentages of future net sales relating to its anthrax vaccine product candidate and related technology.
VXGN has other potentially valuable assets, including a «state - of - the - art biopharmaceutical manufacturing facility with a 1,000 - liter bioreactor that can be used to make cell culture or microbial biologic products» and rights to specified percentages of future net sales relating to its anthrax vaccine product candidate and related technology.
Work in administration and manufacturing or processing of cell therapy products such as TIL, CAR - T cells, and stem cell or blood product transplants.
Demand for semiconductors and other electronics products manufactured using fluorinated GHGs (e.g., flat panel displays, micro-electro-mechanical systems and photovoltaic cells) is expected to continue to rise given high demand for high - tech products and renewable energy.
Lappymaster 11000mAh Power Bank is a high - quality product manufactured by using best quality components and parts including high capacity original A grade Lithium — Ion Cell.
Over 90 % of production of manufacturing cell is on automated equipment, to minimize change - over time, an analysis of the physical properties of each product was performed.
a b c d e f g h i j k l m n o p q r s t u v w x y z